Pharmaceuticals

Sartans Market Research: Growth Projections and Trends 2030

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sartans market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Sartans Market expected to grow between 2026 and 2030?

The sartans market has shown steady expansion in recent years. Its size is expected to climb from $22.18 billion in 2025 to $23.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.1%. This historical growth can be linked to factors such as the high global incidence of hypertension, the prevalence of cardiovascular diseases, the adoption of generic medicines, hospital-based prescribing practices, and the established long-term safety profile of sartans.

The sartans market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach a valuation of $27.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.1%. Factors contributing to this growth during the forecast period include an aging demographic, an increasing prevalence of kidney disease, the need for economical treatments, the expansion of outpatient care, and the rise of digital pharmacies. Key trends anticipated during this period encompass their growing application in hypertension management, the proliferation of generic angiotensin receptor blockers, a leaning towards combination cardiovascular therapies, wider distribution through online pharmacies, and an emphasis on safeguarding renal and cardiovascular health.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

Which Drivers Are Influencing Market Acceleration In The Sartans Market?

The increasing occurrence of hypertension is anticipated to fuel the expansion of the sartans market moving ahead. This condition is characterized by consistently elevated blood pressure, significantly increasing the risk of cardiac issues, strokes, and other serious medical complications. A rising frequency of hypertension is associated with diets high in salt and processed items, which contribute to fluid retention and greater strain on the heart. Sartans manage hypertension by obstructing angiotensin II, a hormone responsible for constricting blood vessels. This action helps to relax and broaden the vessels, thereby reducing blood pressure and lessening the heart’s burden. As an illustration, in September 2025, the World Health Organization, an international public health body based in Switzerland, reported that approximately 1.4 billion adults aged 30–79 years globally were suffering from hypertension in 2024, accounting for around 33% of the world’s population. Consequently, the increasing incidence of hypertension is propelling the growth of the sartans market.

What Segments Are Identified Within The Structure Of The Sartans Market?

The sartans market covered in this report is segmented –

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Other End-Users

Subsegments:

1) By Valsartan: Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations

2) By Telmisartan: Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules

3) By Losartan: Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets

4) By Irbesartan: High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs

5) By Azilsartan: Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets

6) By Olmesartan: Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets

What Trends Are Reshaping The Dynamics Of The Sartans Market?

Leading companies in the sartans market are prioritizing the development of advanced products, such as tablet-form sartans, to boost treatment effectiveness and patient adherence. Tablet-form sartans are oral medications containing sartan drugs that work by blocking the effects of angiotensin II, which helps in relaxing blood vessels and lowering blood pressure. For instance, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, obtained US Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg). These tablets are sold under the brand name Diovan. They are prescribed for managing hypertension and heart failure, improving survival following a heart attack in adults, and are also appropriate for pediatric patients aged one year and older.

Which Leading Companies Dominate The Sartans Market Share?

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

How Does The Sartans Market Perform Across Major Global Regions?

North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sartans Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp

Browse Through More Reports Similar to the Global Sartans Market 2026, By The Business Research Company

Canned Sardines Market Report 2026

https://www.thebusinessresearchcompany.com/report/canned-sardines-global-market-report

Sarcoma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/sarcoma-drugs-global-market-report

Pineapples Market Report 2026

https://www.thebusinessresearchcompany.com/report/pineapples-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795